1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment response and outcomes of grade 3 (G3) pancreatic neuroendocrine carcinomas (HGNEC) based on pathologic differentiation
    Meeting Abstract

    Raj, N. P.; Valentino, E.; Tang, L. H.; Capanu, M.; Basturk, O.; Klimstra, D.; Reidy, D. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Evaluation of local and distant recurrences pattern in patients with triple negative breast cancer according to age
    Meeting Abstract

    Radosa, J. C.; Eaton, A.; Stempel, M.; Khander, A.; Liedtke, C.; Solomayer, E. F.; Gunthner-Biller, M.; Morrow, M.; King, T. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prevalence of hypomagnesemia in patients with HER2-positive breast cancer receiving pertuzumab treatment
    Meeting Abstract

    Proverbs-Singh, T. A.; Cadoo, K. A.; Torre, G.; Patil, S.; Gucalp, A.; Dang, C. T.; Hudis, C. A.; Glezerman, I. G.; Traina, T. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Banked EBV-specific T-cells from HLA-partially matched normal donors to induce durable remissions of rituximab refractory EBV(+) B-cell lymphomas post hematopoietic and organ allografts
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Baroudy, K.; Boulad, F.; Khalaf, R.; Papadopoulos, E. B.; Sauter, C. S.; Szenes, V.; Suser, S.; Wasilewski, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Updated survival results from a randomized, dose-ranging phase II study of nivolumab (NIVO) in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Plimack, E. R.; Hammers, H. J.; Rini, B. I.; McDermott, D. F.; Redman, B.; Kuzel, T.; Harrison, M. R.; Vaishampayan, U. N.; Drabkin, H. A.; George, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is response classification with PERCIST in stage IV breast cancer influenced by the number of lesions assessed?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Molecular signature of patients with pre-treated urothelial carcinoma (UC) achieving extreme responses to pazopanib (PZP) salvage therapy
    Meeting Abstract

    Pinciroli, P.; Iyer, G.; Won, H. H.; Canevari, S.; Colecchia, M.; De Braud, F. G.; Daidone, M. G.; Giannatempo, P.; Raggi, D.; Pennati, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Long-term rates of ipsilateral breast tumor recurrence (IBTR) for women with ductal carcinoma in situ (DCIS) meeting LORIS trial eligibility criteria undergoing standard therapy
    Meeting Abstract

    Pilewskie, M. L.; Olcese, C.; Patil, S.; Van Zee, K. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS)
    Meeting Abstract

    Pietanza, M. C.; Won, H. H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Krug, L. M.; Varghese, A. M.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Final results of phase Ib of tarextumab (TRXT, OMP-59R5, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)
    Meeting Abstract

    Pietanza, M. C.; Spira, A. I.; Jotte, R. M.; Gadgeel, S. M.; Mita, A. C.; Hart, L. L.; Gluck, W. L.; Chiang, A. C.; Liu, S. V.; Kapoun, A. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save